← USPTO Patent Applications

OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES AND THEIR USE

Application US20260077064A1 Kind: A1 Mar 19, 2026

Inventors

Steven Gray

Abstract

This invention relates to polynucleotides comprising a nucleotide sequence encoding a PPT1 polypeptide or a fragment thereof, vectors (viral or non-viral vectors) comprising the same, and methods of using the same for delivery of the open reading frame to a cell or a subject and to treat infantile neuronal lipofuscinosis (infantile Batten disease). The polynucleotides comprise an optimized CLN1 open reading frame.

CPC Classifications

A61K 48/0066 C12N 15/86 C12N 2750/14143 C12N 2750/14145 C12N 2830/002

Filing Date

2025-11-25

Application No.

19400490